For research use only. Not for therapeutic Use.
Tiopinac (RS 40974), a dibenzthiepin, is an orally active and highly potent anti-inflammatory and anti-pyretic agent[1].
Tiopinac (0.03-110 mg/kg) has 40 times the antiphlogistic potency of phenylbutazone. The dose required to reduce paw swelling by 30% is approximately 0.5 mg/kg. Tiopinac does not elicit overt side effects at the 20 mg/kg/day dose. Tiopinac causes a dose-related reversal of the decreases body weight caused by the adjuvant disease, the weight of those rats receiving 0.135 and 0.4 mg/kg/day being significantly greater than that of the positive controls. Tiopinac (0.3-30 mg/kg) is highly potent in inhibiting the pain evoked in the yeastinflamed hind paw of the rat[1].
Catalog Number | I013469 |
CAS Number | 61220-69-7 |
Synonyms | 2-(11-oxo-6H-benzo[c][1]benzothiepin-3-yl)acetic acid |
Molecular Formula | C16H12O3S |
Purity | ≥95% |
InChI | InChI=1S/C16H12O3S/c17-15(18)8-10-5-6-13-14(7-10)20-9-11-3-1-2-4-12(11)16(13)19/h1-7H,8-9H2,(H,17,18) |
InChIKey | KLIVRBFRQSOGQI-UHFFFAOYSA-N |
SMILES | C1C2=CC=CC=C2C(=O)C3=C(S1)C=C(C=C3)CC(=O)O |
Reference | [1]. Rooks WH 2nd, et al. The anti-inflammatory and analgesic profile of 6,11-dihydrodibenzo-[b.e.]-thiepin-11-one-3-acetic acid (tiopinac). Agents Actions. 1980 Jun;10(3):266-73. |